Predicting the development of diabetes using the product of triglycerides and glucose: The chungju metabolic disease cohort (CMC) study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lee, Seung Hwan ^a,b   Kwon, Hyuk Sang ^a,c   Park, Yong Moon ^a,d   Ha, Hee Sung ^a   Jeong, Seung Hee ^a   Yang, Hae Kyung ^a,b   Lee, Jin Hee ^a   Yim, Hyeon Woo ^a   Kang, Moo Il ^a,b   Lee, Won Chul ^a   Son, Ho Young ^a,b   Yoon, Kun Ho ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACADEMIC ACHIEVEMENT; ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT ASSESSMENT; PREDICTION; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; ALCOHOL DRINKING; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 84896529693     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090430     Document Type: Article

References (36)

1. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14.
2. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, et al. (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368: 1681-1688. (Pubitemid 46048556)
3. Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus of Korean Diabetes Association, Park IeB, Kim J, Kim DJ, Chung CH, et al. (2013) Diabetes epidemics in Korea: reappraise nationwide survey of diabetes "diabetes in Korea 2007". Diabetes Metab J 37: 233-239.
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403. (Pubitemid 34437694)
5. Dallmeier D, Larson MG, Wang N, Fontes JD, Benjamin EJ, et al. (2012) Addition of inflammatory biomarkers did not improve diabetes prediction in the community: the framingham heart study. J Am Heart Assoc 1: e000869.
6. Kashima S, Inoue K, Matsumoto M, Akimoto K (2013) Do non-glycaemic markers add value to plasma glucose and hemoglobin a1c in predicting diabetes? Yuport health checkup center study. PLos One 8: e66899.
7. Echouffo-Tcheugui JB, Dieffenbach SD, Kengne AP (2013) Added value of novel circulating and genetic biomarkers in type 2 diabetes prediction: A systematic review. Diabetes Res Clin Pract 101: 255-269.
8. Schulze MB, Weikert C, Pischon T, Bergmann MM, Al-Hasani H, et al. (2009) Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care 32: 2116-2119.
9. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, et al. (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 353: 1454-1462. (Pubitemid 41400919)
10. Rhee SY, Woo JT (2011) The prediabetic period: review of clinical aspects. Diabetes Metab J 35: 107-116.
11. Dotevall A, Johansson S, Wilhelmsen L, Rosengren A (2004) Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med 21: 615-622. (Pubitemid 38746284)
12. Hjellvik V, Sakshaug S, Strøm H (2012) Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women. Clin Epidemiol 4: 213-224.
13. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, et al. (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167: 1068-1074. (Pubitemid 46835795)
14. Tirosh A, Shai I, Bitzur R, Kochba I, Tekes-Manova D, et al. (2008) Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 31: 2032-2037.
15. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6: 299-304.
16. Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, et al. (2010) The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 95: 3347-3351.
17. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915.
18. DeFronzo RA (2009) From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58: 773-795.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
20. The expert committee on the diagnosis and classification of diabetes mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197.
21. The expert committee on the diagnosis and classification of diabetes mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167.
22. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M (2007) What is the best predictor of future type 2 diabetes? Diabetes Care 30: 1544-1548. (Pubitemid 46871168)
23. Hanley AJ, Williams K, Gonzalez C, D'Agostino RB Jr, Wagenknecht LE, et al. (2003) Prediction of type 2 diabetes using sample measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52: 463-469. (Pubitemid 36173204)
24. Lorenzo C, Hazuda HP, Haffner SM (2012) Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart Study. J Clin Endocrinol Metab 97: 793-799.
25. Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, et al. (2011) TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 93: e98-e100.
26. Abbasi F, Reaven GM (2011) Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides 6 glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism 60: 1673-1676.
27. Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, et al. (2013) Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract 67: 665-672.
28. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, et al. (2003) Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139: 802-809.
29. Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M (2010) Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism 59: 299-304.
30. He S,Wang S, Chen X, Jiang L, Peng Y, et al. (2012) Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in general population. Metabolism 61: 30-36.
31. Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, et al. (2010) Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis 9: 85.
32. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulindependent (type II) diabetes mellitus. J Clin Invest 76: 149-155. (Pubitemid 15240430)
33. Kelley DE, Goodpaster BH, Storlien L (2002) Muscle triglyceride and insulin resistance. Annu Rev Nutr 22: 325-346. (Pubitemid 35221465)
34. Tripathy D, Almgren P, Tuomi T, Groop L (2004) Contribution of insulinstimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care 27: 2204-2210. (Pubitemid 39167186)
35. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, et al. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298: 309-316. (Pubitemid 47080485)
36. Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, et al. (2011) Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol 9: 258-270.